Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-101,300
Closed -$4.33M 4038
2017
Q4
$4.33M Buy
101,300
+5,900
+6% +$235K ﹤0.01% 1871
2017
Q3
$3.5M Buy
+95,400
New +$3.85M ﹤0.01% 2069

Other funds holding HOLX

Credit Suisse's HOLX Position: Q1 2024 in Review

Credit Suisse reduced its Hologic (HOLX) stake by 2.1% in Q1 2024, selling an estimated $754K and leaving 480,925 shares worth $37.5M. The position accounts for 0.04% of the portfolio, ranked #447.

Credit Suisse first reported a position in HOLX in Q2 2013 and has held it in 44 quarters since. The position peaked at $76.2M in Q1 2023. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Credit Suisse held 480,925 shares of Hologic worth $37.5M as of Q1 2024.
  • Credit Suisse sold 10,134 Hologic shares in Q1 2024, an estimated $754K.
  • Hologic made up 0.04% of Credit Suisse's portfolio in Q1 2024, its #447 holding.
  • Credit Suisse first reported a position in Hologic in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Hologic position peaked at $76.2M in Q1 2023.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.